Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trial-Reference-Cited by-同舟云学术

Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trial

Published:2018-05 Issue:5 Volume:78 Page:872-881.e6
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Guttman-Yassky Emma,Brunner Patrick M.,Neumann Avidan U.,Khattri Saakshi,Pavel Ana B.,Malik Kunal,Singer Giselle K.,Baum Danielle,Gilleaudeau Patricia,Sullivan-Whalen Mary,Rose Sharon,Jim On Shelbi,Li Xuan,Fuentes-Duculan Judilyn,Estrada Yeriel,Garcet Sandra,Traidl-Hoffmann Claudia,Krueger James G.,Lebwohl Mark G.

Publisher

Elsevier BV

Subject

Dermatology

Reference31 articles.

1. Public health burden and epidemiology of atopic dermatitis;Silverberg;Dermatol Clin,2017

2. Atopic dermatitis;Weidinger;Lancet,2016

3. Epidemiology of atopic dermatitis: a review;DaVeiga;Allergy Asthma Proc,2012

4. Atopic dermatitis: burden of illness, quality of life, and associated complications;Drucker;Allergy Asthma Proc,2017

5. Expert perspectives on management of moderate-to-severe atopic dermatitis: a multidisciplinary consensus addressing current and emerging therapies;Boguniewicz;J Allergy Clin Immunol Pract,2017

Cited by 277 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL-22 in Atopic Dermatitis;Cells;2024-08-22

2. Exploring novel drug targets for atopic dermatitis through plasma proteome with genome;Archives of Dermatological Research;2024-08-13

3. Revisiting immunotherapeutic strategies for the management of atopic dermatitis;Exploration of Asthma & Allergy;2024-08-09

4. Systemic Immunomodulatory Treatments for Atopic Dermatitis;JAMA Dermatology;2024-07-17

5. Single-cell mass cytometry in immunological skin diseases;Frontiers in Immunology;2024-07-16